BioCentury
ARTICLE | Clinical News

NeXstar regulatory update

July 31, 1995 7:00 AM UTC

NXTR's Vestar Inc. subsidiary (San Dimas, Calif.) received U.S. Patent No. 5,435,989 covering methods for the liposomal targeting of tumors. The patent describes the mechanism of action that enables ...